rs17127203

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001854.4(COL11A1):​c.4608+18A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.121 in 1,607,942 control chromosomes in the GnomAD database, including 13,632 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1360 hom., cov: 33)
Exomes 𝑓: 0.12 ( 12272 hom. )

Consequence

COL11A1
NM_001854.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.0560

Publications

10 publications found
Variant links:
Genes affected
COL11A1 (HGNC:2186): (collagen type XI alpha 1 chain) This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Mutations in this gene are associated with type II Stickler syndrome and with Marshall syndrome. A single-nucleotide polymorphism in this gene is also associated with susceptibility to lumbar disc herniation. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]
COL11A1 Gene-Disease associations (from GenCC):
  • Marshall syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • Stickler syndrome type 2
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, PanelApp Australia, Orphanet, Genomics England PanelApp
  • fibrochondrogenesis 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • hearing loss, autosomal dominant 37
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • fibrochondrogenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive Stickler syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 1-102888559-T-C is Benign according to our data. Variant chr1-102888559-T-C is described in ClinVar as Benign. ClinVar VariationId is 258467.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.235 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL11A1NM_001854.4 linkc.4608+18A>G intron_variant Intron 62 of 66 ENST00000370096.9 NP_001845.3 P12107-1Q59HB5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL11A1ENST00000370096.9 linkc.4608+18A>G intron_variant Intron 62 of 66 1 NM_001854.4 ENSP00000359114.3 P12107-1

Frequencies

GnomAD3 genomes
AF:
0.125
AC:
19015
AN:
152108
Hom.:
1362
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.163
Gnomad AMI
AF:
0.0340
Gnomad AMR
AF:
0.0929
Gnomad ASJ
AF:
0.0732
Gnomad EAS
AF:
0.247
Gnomad SAS
AF:
0.242
Gnomad FIN
AF:
0.0437
Gnomad MID
AF:
0.0918
Gnomad NFE
AF:
0.108
Gnomad OTH
AF:
0.117
GnomAD2 exomes
AF:
0.131
AC:
32699
AN:
250224
AF XY:
0.133
show subpopulations
Gnomad AFR exome
AF:
0.163
Gnomad AMR exome
AF:
0.102
Gnomad ASJ exome
AF:
0.0752
Gnomad EAS exome
AF:
0.271
Gnomad FIN exome
AF:
0.0479
Gnomad NFE exome
AF:
0.108
Gnomad OTH exome
AF:
0.110
GnomAD4 exome
AF:
0.120
AC:
175342
AN:
1455716
Hom.:
12272
Cov.:
29
AF XY:
0.123
AC XY:
88972
AN XY:
724614
show subpopulations
African (AFR)
AF:
0.166
AC:
5536
AN:
33364
American (AMR)
AF:
0.0999
AC:
4459
AN:
44622
Ashkenazi Jewish (ASJ)
AF:
0.0748
AC:
1951
AN:
26090
East Asian (EAS)
AF:
0.295
AC:
11679
AN:
39622
South Asian (SAS)
AF:
0.220
AC:
18959
AN:
86118
European-Finnish (FIN)
AF:
0.0516
AC:
2755
AN:
53366
Middle Eastern (MID)
AF:
0.112
AC:
644
AN:
5756
European-Non Finnish (NFE)
AF:
0.110
AC:
122140
AN:
1106622
Other (OTH)
AF:
0.120
AC:
7219
AN:
60156
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
8457
16914
25372
33829
42286
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4692
9384
14076
18768
23460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.125
AC:
19016
AN:
152226
Hom.:
1360
Cov.:
33
AF XY:
0.123
AC XY:
9182
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.163
AC:
6777
AN:
41542
American (AMR)
AF:
0.0929
AC:
1419
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.0732
AC:
254
AN:
3470
East Asian (EAS)
AF:
0.246
AC:
1274
AN:
5172
South Asian (SAS)
AF:
0.241
AC:
1164
AN:
4826
European-Finnish (FIN)
AF:
0.0437
AC:
464
AN:
10614
Middle Eastern (MID)
AF:
0.0918
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
0.108
AC:
7362
AN:
68004
Other (OTH)
AF:
0.115
AC:
244
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
840
1680
2521
3361
4201
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
224
448
672
896
1120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.113
Hom.:
391
Bravo
AF:
0.127
Asia WGS
AF:
0.230
AC:
800
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 03, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
5.5
DANN
Benign
0.42
PhyloP100
-0.056
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17127203; hg19: chr1-103354115; COSMIC: COSV62172744; COSMIC: COSV62172744; API